Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
09/09/24 | $5,000,000 | Seed |
BVF Partners Dawn Biopharma INCE Capital Salvia | undisclosed |